Key result
Worksite pharmacist case management lowers systolic blood pressure by ~8 mmHg in high-risk employees.
Why the study?
Established cardiovascular risk factors remain uncontrolled in many Canadians, and worksite-based screening and management represent an untapped strategy to optimize risk factor control.
Mean Difference: -8
p-value: p=0.03
Supports feasibility of worksite pharmacist case management for CV risk reduction; hypothesis-generating and requires confirmation in randomized trials.
Background: Established cardiovascular risk factors are highly prevalent and contribute substantially to cardiovascular morbidity and mortality because they remain uncontrolled in many Canadians. Worksite-based cardiovascular risk factor screening and management represent a largely untapped strategy for optimizing risk factor control. Methods: In a 2-phase collaborative demonstration project between Alberta Health Services (AHS) and the Alberta Newsprint Company (ANC), ANC employees were offered cardiovascular risk factor screening and management. Screening was performed at the worksite by AHS nurses, who collected baseline history, performed automated blood pressure measurement and point-of-care testing for lipids and A1c, and calculated 10-year Framingham risk. Employees with a Framingham risk score of ≥10% and uncontrolled blood pressure, dyslipidemia, or smoking were offered 6 months of pharmacist case management to optimize their risk factor control. Results: In total, 87 of 190 (46%) employees volunteered to undergo cardiovascular risk factor screening. Mean age was 44.5±11.9 years, 73 (83.9%) were male, 14 (16.1%) had hypertension, 4 (4.6%) had diabetes, 12 (13.8%) were current smokers, and 9 (10%) had dyslipidemia. Of 36 employees with an estimated Framingham risk score of ≥10%, 21 (58%) agreed to receive case management and 15 (42%) attended baseline and 6-month follow-up case management visits. Statistically significant reductions in left arm systolic blood pressure (−8.0±12.4 mmHg; p =0.03) and triglyceride levels (−0.8±1.4 mmol/L; p =0.04) occurred following case management. Conclusion: These findings demonstrate the feasibility and usefulness of collaborative, worksite-based cardiovascular risk factor screening and management. Expansion of this type of partnership in a cost-effective manner is warranted.
No takes yet. Share an insight, caveat, or question.
Padwal et al. (2017) studied Cardiovascular risk factors (n=87). Worksite-based cardiovascular risk screening and pharmacist case management was evaluated on Change in left arm systolic blood pressure (MD -8.0 mmHg, p=0.03). Worksite-based pharmacist case management for high-risk employees significantly reduced systolic blood pressure by a mean of 8.0 mmHg and triglyceride levels by 0.8 mmol/L over 6 months.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: